Pirouette Medical (Seed)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$55,000,000

Company Info
Founders
Conor Cullihane
Company Description
Pirouette is initially developing an epinephrine auto-injector (EAI), which is used for the emergency treatment of severe allergic reactions. Pirouette Medical develops a portable, intuitive, and easy-to-use auto-injector.
Market
Healthcare & Wellness
Coinvestors
Asymmetry Ventures,Safar Partners

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement